1. J.S. Smolen, R. Landewé. Eular Recommendations for the Management of Rheumatoid Arthritis – 2016 Update. http://www.eular.org/myUploadData/files/EULAR RA Management recommendations 2016 update June 2016-c_2.pdfAvailable from: http://www.eular.org/myUploadData/files/EULAR%20RA%20Management%20recommendations%202016%20update%20June%202016-c_2.pdf 2016 [cited 31.10.16].
2. Teratogen update: reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child;Brent;Teratology,2001
3. Aventis Pharmaceuticals Inc. Arava Tablets (leflunomide). Contraindications and Warnings. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20905slr007,20905se1-006_arava_lbl.pdf 2003 [cited 31.10.16].
4. Teratogenicity study of the dihydroorotate-dehydrogenase inhibitor and protein tyrosine kinase inhibitor Leflunomide in mice;Fukushima;Reprod. Toxicol.,2007
5. Unintended pregnancy: worldwide levels, trends, and outcomes;Singh;Stud. Fam. Plann.,2010